BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22939347)

  • 1. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.
    Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S
    Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
    Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
    Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.
    Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X
    Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of TRAIL treatment against HPV16 infected cervical cancer cells undergoing senescence following siRNA knockdown of E6/E7 genes.
    Eaton S; Wiktor P; Thirstrup D; Lake D; Nagaraj VJ
    Biochem Biophys Res Commun; 2011 Feb; 405(1):1-6. PubMed ID: 21167816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
    Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
    Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
    Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
    Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery efficacy of polyethyleneimine-introduced chitosan shell/poly(methyl methacrylate) core nanoparticles for rat mesenchymal stem cells.
    Pimpha N; Sunintaboon P; Inphonlek S; Tabata Y
    J Biomater Sci Polym Ed; 2010; 21(2):205-23. PubMed ID: 20092685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
    Kim MS; Bak Y; Park YS; Lee DH; Kim JH; Kang JW; Song HH; Oh SR; Yoon DY
    Cell Biol Toxicol; 2013 Aug; 29(4):259-72. PubMed ID: 23955116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY; Peng ZL; Wang H
    Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.